Research Programs: Cancer Outcomes and Survivorship, Transplant Biology and Therapy
Assistant Professor, Department of Medicine

arora005@umn.edu
612-626-4105 — office

Dr. Arora's clinical profile
(University of Minnesota Physicians Web site)

Research Interests

New therapies for management of chronic graft-versus-host disease (CGVHD) and methods to improve outcomes following transplantation therapy for multiple myeloma.

Selected Publications

Laudi N, Arora M, Burns LJ, Miller JS, McGlave PB, Barker JN, Ramsay NK, Orchard PJ, Macmillan ML, Weisdorf DJ. Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma. Biol Blood Marrow Transplant. 2005 Feb; 11(2):129-35.

Arora M, McGlave PB, Burns LJ, Miller JS, Barke JN, Defor TE, Weisdorf DJ. Results of autologous and allogeneic hematopoietic cell transplant therapy for multiple myeloma. Bone Marrow Transplant. 2005 Jun;35(12):1133-40.

Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma. Biol Blood Marrow Transplant. 2004 Jun;10(6):395-404.

Akpek G, Lee SJ, Flowers ME, Pavletic SZ, Arora M, Lee S, Piantadosi S, Guthrie KA, Lynch JC, Takatu A, Horowitz MM, Antin JH, Weisdorf DJ, Martin PJ, Vogelsang GB. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood. 2003 Aug 1; 102(3):802-9. Epub 2003 Apr 24.

Arora M, Burns LJ, Davies SM, Macmillan ML, Defor TE, Miller WJ, Weisdorf DJ. Chronic graft-versus-host disease: a prospective cohort study. Biol Blood Marrow Transplant. 2003 Jan; 9(1):38-45.